The blurring of boundaries between hitherto distinct scientific disciplines, technologies or... mehr
Produktinformationen "The Anticipation of Converging Industries"
The blurring of boundaries between hitherto distinct scientific disciplines, technologies or markets is a common and powerful phenomenon. Subjects of this convergence often change consumer behaviours, favouring products and platforms with multiple functions. The Anticipation of Converging Industries provides a detailed focus on the triggers, drivers and consequences of convergence to create a more concise definition of convergence. This detailed analysis includes a specifically developed toolbox for 'convergence foresight', creating a forecasting method for convergence trends. With the focus on the chemical, biotechnological and pharmaceutical industries, several indicators of convergence in the areas of Nutraceuticals/Functional Foods, Cosmeceuticals and ICT are derived from samples including over 1million patents and scientific publications. By supporting this methodical approach with real world data, The Anticipation of Converging Industries is perfect for industry practitioners looking for a competitive edge in the present and for the future. Similarly, academics will find a comprehensive theoretical concept for better understanding the underlying rationale of convergence at their disposal von Curran, Clive-Steven
Weiterführende Links zu "The Anticipation of Converging Industries"
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "The Anticipation of Converging Industries"
Bewertungen werden nach Überprüfung freigeschaltet.
Curran, Clive-Steven mehr
Clive-Steven Curran studied biotechnology at the University of Muenster and the Hamburg University of Technology. He earned his PhD at the University of Muenster, Faculty of Chemistry & Pharmaceutical Sciences (in business administration in the natural sciences), where he also conducted his Post-Doc research. He now works as a Manager Global Patent Strategy for Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis services and products. His daily work is concerned with innovation management, strategic patent activities, economic evaluation and licensing."